GConferenceGridThe Conference Catalogue · Vol. 2027Folio № 7B24B4
Healthcare & Medical

LSX Investival Showcase USA 2027

I

nvestival Showcase USA is North America's premier biotech, medtech, and digital health networking event, connecting life science and healthcare innovators with investors and partners through exclusive 1:1 sessions. Building on a decade of European success, this event brings a dynamic partnering format stateside. Attendees include startups, investors, and in…

Visit the official site
12Voices
4Underwriters
0Exhibitors
10On the bill · sessions
16Companies · in total
§I

The Voices

Programmed at LSX, in alphabetical order.
Andrew Lam
Managing Director, Head, Biotech Private Equity · Ally Bridge Group
Anna Argo
Chief Business Officer · Cytotheryx
Elena Itskovich
Founding General Partner · Nest Catalyst Ventures
Hal Paz
Operating Partner · Khosla Ventures
Heather Turner
CEO & Director · LB Pharmaceuticals
Jamil Beg
Partner · SV Health Investors
Jessica Federer
Investor & Board Member · Angelini Ventures
Katerina Fialkovskaya
Investment Director · Philips Ventures
Michael Aberman
General Partner · Regeneron Ventures
Renée Aguiar-Lucander
CEO · Hansa Biopharma
Stella Vnook
Executive Chair & Founder · Kaida & Oral Biolife
Suguna Rachakonda
VP, Business Development · Insilico Medicine
§II

Underwritten By

The houses behind the program. Tiers as disclosed.
1004 Venture Partners
AAA Family Office
Melior Capital Management
Neuvation Ventures
§III

The Programme

Selected from 10 sessions on the bill.
  • 10:30am - 11:15am

    South Florida - The Rising Life Science Hub

    South Florida is solidifying its position as a national healthcare and life sciences hub. With its strategic location, growing infrastructure, and influx of investment, the city is…

    Headliner Stage
  • 11:15am - 12:00pm

    How to Get Funded as a Medtech Startup

    - Crafting a compelling value proposition that resonates with investors - Understanding the unique funding challenges in the medtech sector - Preparing for regulatory hurdles that …

    Medtech & Digital Health Stage
  • 11:15am - 12:00pm

    Strategic IP: Maximizing the Value of Your Most Precious Assets

    Is your company’s intellectual property pieces of paper you pray never get a close look, or is it the true crown jewel of your business? This masterclass will address how biotechno…

    Headliner Stage
  • 12:00pm - 12:45pm

    Strategic Considerations for Global Expansion for Life Science Startups

    - Which markets are currently most desirable for startups and why? - Navigating varied and complex regulatory requirements across China, Europe, and the Middle East - Discussing th…

    Headliner Stage
  • 1:45pm - 2:30pm

    Women’s Health - The Trillion Dollar Opportunity

    - Overview of the growth we’ve seen in the space in recent years - Highlighting breakthroughs in diagnostics, therapeutics, and digital health solutions tailored to women’s needs -…

    Headliner Stage
  • 2:30pm - 3:15pm

    TechBio – The Science, Investment & Business Models

    - How do we define TechBio? - Strategies for securing investment in a competitive and evolving market - Discussing the key metrics that define ROI in TechBio - Identify what sets s…

    Headliner Stage
  • 3:15pm - 4:00pm

    The Path to Public: Mastering Your Exit Strategy

    - How to adapt exit strategies in a cautious and unpredictable financial landscape - Beyond the IPO - exploring alternative pathways to liquidity that are gaining traction in today…

    Headliner Stage
  • 4:30pm - 5:15pm

    Fuelling Innovation: The Role of Corporate Venture Capital in Life Sciences

    As life sciences evolve, corporate venture capital (CVC) is becoming a critical driver of innovation. This panel brings together CVC leaders to share insights into their investment…

    Headliner Stage
  • 9:00am - 9:05am

    LSX Welcome

    Headliner Stage
Intermission
Part the Second · For the Buyer

An audience of 16 companies, parsed from the program.

Sixteen companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

01Fig. 01 — Composition of the House
0All threespeak · spons · exh
4Sponsoringsponsor only
0Exhibitingexhibitor only
12Speakingspeaker only
02Fig. 02 — The Voices, by Seniority

92% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite325%
  • Founder / Owner542%
  • VP-level18%
  • Director / Head of217%
  • Advisor / Investor18%

Of 12 on the bill · classified by free-text title

03Fig. 03 — The Heaviest in the Room
  1. 011004 Venture PartnersSp
  2. 02AAA Family OfficeSp
  3. 03Melior Capital ManagementSp
  4. 04Neuvation VenturesSp
  5. 05Ally Bridge Group1V
  6. 06Angelini Ventures1V
  7. 07Cytotheryx1V
  8. 08Hansa Biopharma1V
  9. 09Insilico Medicine1V
  10. 10Kaida & Oral Biolife1V
  11. 11Khosla Ventures1V
  12. 12LB Pharmaceuticals1V
  13. 13Nest Catalyst Ventures1V
  14. 14Philips Ventures1V
04Fig. 04 — By Tier
unspecified4
100% of 4